Select Medical (SEM) reported Q1 earnings from continuing operations late Thursday of $0.44 per diluted share, up from $0.33 a year earlier.
Analysts polled by FactSet expected $0.46.
Revenue for the quarter ended March 31 was $1.35 billion compared with $1.32 billion a year earlier.
Analysts surveyed by FactSet expected $1.39 billion.
The company reaffirmed its 2025 earnings of $1.09 to $1.19 per diluted share. Analysts surveyed by FactSet expect $1.12. The company Trimmed annual revenue guidance to $5.3 billion to $5.5 billion from $5.4 billion to $5.6 billion. Analysts polled by FactSet expect $5.46 billion.
Shares of the company fell more than 3% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。